Treatment of antipsychotic associated obesity with a GLP-1 Analogue: the TAO study Behandling af antipsykotika-associeret fedme med en GLP-1 analog: TAO studiet
Phase of Trial: Phase IV
Latest Information Update: 23 Dec 2013
At a glance
- Drugs Exenatide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms TAO
- 07 Jun 2017 Biomarkers information updated
- 23 Dec 2013 Last checked against ClinicalTrials.gov record.
- 15 Feb 2013 Planned End Date (Jul 2014) added as reported by ClinicalTrials.gov.